business / markets
14 hours ago

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

https://www.cnbc.com/2025/02/21/hims-hers-shares-fall-after-fda-says-semaglutide-no-longer-in-shortage.htmlhttps://www.cnn.com/2025/02/21/health/ozempic-wegovy-shortage-over-fda-says/index.htmlhttps://apnews.com/article/wegovy-ozempic-obesity-diabetes-treatment-shortage-a5f94b1dd7449e15a17922f5503354d6
Cnbc.com and 3 more
Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage Open in Cnbc.com
Vote 5
0

References

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

https://www.cnbc.com/2025/02/21/fda-shortage-of-novo-nordisks-wegovy-and-ozempic-drugs-is-resolved.htmlCnbc.com
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

Ozempic and Wegovy are no longer in shortage, FDA says | CNN

https://www.cnn.com/2025/02/21/health/ozempic-wegovy-shortage-over-fda-says/index.htmlCnn.com
Ozempic and Wegovy are no longer in shortage, FDA says | CNN

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

https://apnews.com/article/wegovy-ozempic-obesity-diabetes-treatment-shortage-a5f94b1dd7449e15a17922f5503354d6Apnews.com
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Related Articles

Log in to continue reading

Unlimited Access
Personalized Feed
Full Experience

By continuing, you agree to the Privacy Policy. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.